ArticleJournal of orthopaedic surgery and research2025
Cross-cultural validation of the Fukushima lumbar spinal stenosis scale in Korean patients with degenerative lumbar spinal stenosis.
Article in Journal of orthopaedic surgery and research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- External validity and responsiveness of lumbar spinal stenosis-specific symptom and QOL scales: A multicenter prospective study.Scientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe Fukushima Lumbar Spinal Stenosis Scale (FLS-25) is a disease-specific patient-reported outcome measure developed to assess the symptoms and functional impact of lumbar spinal stenosis (LSS). However, no Korean version of the FLS-25 has been validated to date. This study aimed to assess the reliability, validity, and responsiveness of a Korean adaptation of the FLS-25 (K-FLS-25) using a structured cross-cultural adaptation process.
methodsThe original FLS-25 questionnaire was translated into Korean following established guidelines for cross-cultural adaptation, including forward translation, synthesis, back-translation, expert committee review, and pretesting. The finalized Korean version (K-FLS-25) was initially administered to 140 consecutive patients diagnosed with LSS. Of these, 123 patients completed both the baseline and follow-up assessments and were included in the final analysis. To evaluate construct validity, participants also completed the validated Korean version of the Oswestry Disability Index (ODI) and a Visual Analog Scale (VAS) for back and leg pain. Reliability was assessed through item-wise agreement using kappa statistics, test-retest reliability via the intraclass correlation coefficient (ICC [2,1]), and internal consistency using Cronbach's α. Construct validity was evaluated by calculating Pearson's correlation coefficients between K-FLS-25, ODI, and VAS scores.
resultsAll items of the K-FLS-25 demonstrated substantial agreement, with kappa values exceeding 0.6. The test-retest reliability was excellent (ICC [2,1] = 0.93), and internal consistency was high (Cronbach's α = 0.901). Construct validity was supported by significant Pearson's correlation coefficients between the total and domain scores of K-FLS-25 and the scores of the ODI and VAS for both back and leg pain. As part of cultural adaptation, a prefinal version was tested in 30 Korean-speaking LSS patients, who reported good comprehension without major issues. The final version was confirmed by expert consensus.
conclusionsThe K-FLS-25 was successfully translated and culturally adapted for Korean-speaking patients. It demonstrated excellent reliability, validity, and responsiveness, supporting its suitability as a disease-specific instrument for evaluating symptoms, functional disability, and treatment-related changes in patients with lumbar spinal stenosis in Korea.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.